quantisnow
FeedTopReportsPricing
⌘K
Live feed
01:30:00·23d
PRRelease
Galapagos NV logo

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

GLPG· Galapagos NV
Health Care
Original source

Companies

  • GLPG
    Galapagos NV
    Health Care

Recent analyst ratings

  • Oct 22UpdateLeerink Partners$40.00
  • Aug 5UpdateDeutsche Bank-
  • Feb 14UpdateMorgan Stanley$22.00
  • Nov 20UpdateKepler-
  • Sep 9UpdateLeerink Partners$24.00
  • Aug 2UpdateRaymond James-

Related

  • SEC24d
    SEC Form 6-K filed by Galapagos NV
  • SEC24d
    SEC Form 6-K filed by Galapagos NV
  • SEC28d
    SEC Form 20-F filed by Galapagos NV
  • PR28d
    Galapagos Announces Nomination of Gino Santini to its Board of Directors
  • PR28d
    Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings
  • PR31d
    Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
  • SEC37d
    SEC Form 6-K filed by Galapagos NV
  • PR37d
    Galapagos Receives Transparency Notification from Bank of America
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022